サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1536182

アノレキシアントの世界市場

Anorexiants

出版日
ページ情報
英文 273 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
アノレキシアントの世界市場
出版日: 2024年08月16日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 273 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

アノレキシアントの世界市場は2030年までに11億米ドルに達する見込み

2023年に8億7,320万米ドルと推定されるアノレキシアントの世界市場は、分析期間2023-2030年にCAGR 3.1%で成長し、2030年には11億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである経口投与は、CAGR 3.5%を記録し、分析期間終了時には7億20万米ドルに達すると予測されます。皮下投与セグメントの成長率は、分析期間中CAGR 2.6%と推定されます。

米国市場は2億3,790万米ドルと推定、中国はCAGR 6.1％で成長すると予測

米国のアノレキシアント市場は、2023年に2億3,790万米ドルと推定されます。世界第2位の経済大国である中国は、2023年から2030年にかけてCAGR 6.1%で推移し、2030年には2億2,250万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.0％と2.4％と予測されています。欧州では、ドイツがCAGR 1.6%で成長すると予測されています。

世界のアノレキシアント場- 主要動向と促進要因まとめ

食欲抑制剤としても知られるアノレキシアントは、食欲を減退させ体重減少を補助するように設計された医薬品化合物であり、主に肥満の治療に使用されます。これらの薬剤は中枢神経系に作用して満腹感や満腹感をもたらし、患者の摂取カロリーを減らすのを助けています。一般的に処方されるアノレキシアントには、フェンテルミン、ジエチルプロピオン、そしてlorcaserinのような新しいものがあり、これらは気分と食欲をコントロールする脳内物質の放出を刺激することによって作用します。これらの薬剤の効果は、身体活動の増加や食生活の改善など、ライフスタイルの変化と組み合わせることで高まることが多いです。これらの薬剤は、糖尿病、心臓病、高血圧など多くの慢性疾患と関連している肥満の管理に大きな利点をもたらす一方で、心拍数の増加、血圧の上昇、依存性の問題の可能性など、潜在的な副作用やリスクも伴います。そのため、ヘルスケア・プロバイダーによる慎重な患者のスクリーニングとモニタリングが必要となります。

過去数年間、アノレキシアント市場は医薬品開発と規制当局の承認プロセスにおいてかなりの進歩を遂げてきました。空腹感や満腹感に関与する生化学的経路の理解が進むにつれ、製薬会社は副作用の可能性が少ない新たな経路を標的とする薬剤の開発に注力しています。例えば、食欲調節に関与する複数の経路を標的とする併用療法は、副作用を最小限に抑えながら減量効果を高めることが期待されています。さらに、肥満治療において個別化医療が重視されるようになってきており、遺伝子やバイオマーカーのプロファイリングを用いて、個々の患者のニーズに合わせて薬物療法を調整することで、有効性を向上させ、治療に関連する合併症を減少させることができます。この分野はまた、世界の肥満の有病率の上昇と、効果的な体重管理ソリューションに対する市場の大きな需要に後押しされ、研究開発への投資が増加していることも追い風となっています。

アノレキシアント市場の成長は、世界の肥満の蔓延の深刻化、肥満に伴う健康リスクに対する臨床的理解の深まり、予防ヘルスケアの重視の高まりなど、いくつかの要因によってもたらされます。食生活の変化や運動量の減少によって肥満率が世界的に上昇する中、効果的な治療ソリューションに対する需要は増加の一途をたどっています。さらに、ヘルスケアプロバイダーと患者は、糖尿病や心血管疾患などの関連する健康問題を予防するために体重を管理することの重要性を認識するようになっています。医薬品研究開発における技術的進歩も市場拡大に重要な役割を果たしており、食欲制御の特定の分子経路を標的とするように設計された新薬が市場に参入しています。消費者の行動は、より副作用が少なく、より効果が持続する薬を好む方向にシフトしており、次世代のアノレキシアントの開発に影響を与えています。さらに、革新的な肥満治療薬の早期承認に向けた規制当局の支援が、これらの治療薬の急速な進歩と利用可能性を促進しています。これらの要因が総合的にアノレキシアント市場の成長を後押ししており、効果的で安全かつ利用しやすい肥満治療の必要性が広く認識されていることを反映しています。

調査対象企業の例（全86件）

  • Arena Pharmaceuticals Inc.
  • Bausch Health Companies Inc.
  • CHEPLAPHARM Arzneimittel GmbH
  • Cigna Healthcare
  • Currax Pharmaceuticals LLC（CONTRAVE）
  • Elite Pharmaceuticals Inc.
  • Epic Pharma LLC
  • Hi-Tech Pharmaceuticals
  • KVK Tech Inc.
  • Lannett Co. Inc.
  • Novartis AG
  • Novo Nordisk AS
  • Pfizer Inc.
  • Productos Medix SA de CV
  • VIVUS LLC;

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP26647

Global Anorexiants Market to Reach US$1.1 Billion by 2030

The global market for Anorexiants estimated at US$873.2 Million in the year 2023, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 3.1% over the analysis period 2023-2030. Oral Administration, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$700.2 Million by the end of the analysis period. Growth in the Subcutaneous Administration segment is estimated at 2.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$237.9 Million While China is Forecast to Grow at 6.1% CAGR

The Anorexiants market in the U.S. is estimated at US$237.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$222.5 Million by the year 2030 trailing a CAGR of 6.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.0% and 2.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.6% CAGR.

Global Anorexiants Market - Key Trends and Drivers Summarized

Anorexiants, also known as appetite suppressants, are pharmaceutical compounds designed to decrease appetite and aid in weight loss, primarily used in the treatment of obesity. These drugs affect the central nervous system to create a feeling of satiety or fullness, helping patients to consume fewer calories. Commonly prescribed anorexiants include phentermine, diethylpropion, and newer entries like lorcaserin, which work by stimulating the release of brain chemicals that control mood and appetite. The effectiveness of these medications is often enhanced when combined with lifestyle changes, such as increased physical activity and dietary modifications. While these medications offer significant benefits in managing obesity, which is linked to numerous chronic diseases like diabetes, heart disease, and hypertension, they also come with potential side effects and risks such as increased heart rate, elevated blood pressure, and potential dependency issues. This necessitates careful patient screening and monitoring by healthcare providers.

Over the past few years, the anorexiants market has seen considerable advancements in drug development and regulatory approval processes. With a growing understanding of the biochemical pathways involved in hunger and satiety, pharmaceutical companies have been focusing on developing drugs that target new pathways with potentially fewer side effects. For instance, combination therapies that target multiple pathways involved in appetite regulation are showing promise in enhancing weight loss outcomes while minimizing adverse effects. Additionally, there is a growing emphasis on personalized medicine in obesity treatment, where genetic and biomarker profiling is used to tailor drug therapies to individual patient needs, thereby improving efficacy and reducing treatment-related complications. The field has also benefited from increased investment in research and development, driven by the rising prevalence of obesity worldwide and the substantial market demand for effective weight management solutions.

The growth in the anorexiants market is driven by several factors, including an escalating global obesity epidemic, greater clinical understanding of the health risks associated with obesity, and an increasing emphasis on preventive healthcare. As obesity rates climb globally, driven by changes in diet and decreases in physical activity, the demand for effective treatment solutions continues to rise. Furthermore, healthcare providers and patients are becoming more aware of the importance of managing weight to prevent associated health issues such as diabetes and cardiovascular diseases. Technological advancements in drug research and development are also playing a crucial role in the market expansion, with new drugs designed to target specific molecular pathways of appetite control entering the market. Consumer behavior is shifting towards favoring medications with fewer side effects and more sustained effects, influencing the development of next-generation anorexiants. In addition, regulatory support for fast-tracking the approval of innovative obesity treatments is fostering rapid advancements and availability of these medications. Collectively, these factors are propelling the growth of the anorexiants market, reflecting a broad recognition of the need for effective, safe, and accessible obesity treatments.

Select Competitors (Total 86 Featured) -

  • Arena Pharmaceuticals Inc.
  • Bausch Health Companies Inc.
  • CHEPLAPHARM Arzneimittel GmbH
  • Cigna Healthcare
  • Currax Pharmaceuticals LLC (CONTRAVE)
  • Elite Pharmaceuticals Inc.
  • Epic Pharma LLC
  • Hi-Tech Pharmaceuticals
  • KVK Tech Inc.
  • Lannett Co. Inc.
  • Novartis AG
  • Novo Nordisk AS
  • Pfizer Inc.
  • Productos Medix SA de CV
  • VIVUS LLC;

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Anorexiants - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Prevalence of Obesity Throws the Spotlight on Anorexiants
    • Growing Acceptance of Pharmacotherapy in Weight Management Expands Addressable Market
    • Consumer Demand for Non-Surgical Weight Loss Solutions Drives Adoption of Anorexiants
    • Increasing Spending Weight Management Products Bodes Well for Market Growth
    • Rising Incidence of Diabetes and Cardiovascular Diseases Linked to Obesity Spurs Demand for Anorexiants
    • Emergence of Generic Drugs Challenges Growth but Expands Accessibility in Anorexiants Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Anorexiants Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Anorexiants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Anorexiants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Anorexiants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Oral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Subcutaneous Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Subcutaneous Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Subcutaneous Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Anorexiants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • JAPAN
    • Anorexiants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • CHINA
    • Anorexiants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • EUROPE
    • Anorexiants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Anorexiants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Anorexiants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Anorexiants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • FRANCE
    • Anorexiants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • GERMANY
    • Anorexiants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Anorexiants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Anorexiants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Anorexiants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Anorexiants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Anorexiants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Anorexiants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • INDIA
    • Anorexiants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Anorexiants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Anorexiants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Anorexiants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Anorexiants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Anorexiants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Anorexiants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Anorexiants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Anorexiants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • AFRICA
    • Anorexiants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Anorexiants by Route Of Administration - Oral Administration and Subcutaneous Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Anorexiants by Route Of Administration - Percentage Breakdown of Value Sales for Oral Administration and Subcutaneous Administration for the Years 2014, 2024 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Anorexiants by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Anorexiants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030

IV. COMPETITION